We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

8002:TSEMarubeni Corporation Analysis

Data as of 2026-03-10 - not real-time

¥5,413.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Marubeni Corp (8002.T) is trading at ¥5,413, comfortably above its 20‑day SMA (¥5,775) and 50‑day SMA (¥5,249) while still below the 52‑week high of ¥6,328, indicating a bullish bias with room to run. The RSI sits at 47, suggesting the stock is not yet overbought, and the MACD histogram is negative, flagging short‑term pressure but not a decisive reversal. Fundamentals show a solid 7.7% revenue growth, a respectable ROE of 12.9%, and a healthy dividend yield of 2.09% with a payout ratio under 30%, pointing to sustainable income. However, the DCF‑derived fair value of ¥754 is far below the market price, raising concerns of overvaluation despite a P/E of 15.7 that is well under the industry average of 29.5. The company’s beta of 0.58 and stable volume suggest modest market sensitivity, though a 30‑day volatility of 56% signals notable price swings.
Overall, the stock balances growth prospects from its diversified industrial portfolio with valuation headwinds; investors should weigh the strong dividend and earnings momentum against the price premium and elevated short‑term technical weakness.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above 20‑day SMA but MACD bearish signal
  • RSI near neutral indicating limited upside
  • Strong dividend yield supporting demand

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustained revenue growth and solid ROE
  • P/E well below industry average
  • Support level at ¥4,952 providing downside cushion

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Diversified global operations reducing single‑market exposure
  • High debt‑to‑equity (63) offset by ample cash reserves
  • Stable dividend policy offering income certainty

Key Metrics & Analysis

Financial Health

Revenue Growth7.70%
Profit Margin6.19%
P/E Ratio15.7
ROE12.85%
ROA2.07%
Debt/Equity63.00
P/B Ratio2.1
Op. Cash Flow¥540.8B
Free Cash Flow¥177.8B
Industry P/E29.5

Technical Analysis

TrendBullish
RSI47.3
Support¥4,952.00
Resistance¥6,328.00
MA 20¥5,775.45
MA 50¥5,248.88
MA 200¥3,888.64
MACDBearish
VolumeStable
Fear & Greed Index75.89

Valuation

Fair Value¥753.70
Target Price¥5,740.00
Upside/Downside6.04%
GradeOvervalued
TypeBlend
Dividend Yield2.09%

Risk Assessment

Beta0.58
Volatility55.94%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.